98%
921
2 minutes
20
Purpose: To investigate the short-term results of single-session treatment of iliocaval and iliofemoral DVT using a single thrombectomy device.
Materials And Methods: This prospective pilot study analyzed patients with acute iliocaval or iliofemoral DVT treated in a single session using the JETi thrombectomy system. All analyses were performed on an intention-to-treat basis. The cohort consisted of 53 limbs in 47 patients (27 women), with a mean age of 57 years (range, 16-88 years). The primary safety and efficacy endpoints were freedom from major adverse events (MAEs) and reestablishment of unobstructed flow in a single session, respectively.
Results: The mean duration of symptoms was 8.5 days ± SD 9.2, with 10 patients (11 limbs, 21.3%) presenting with a symptom duration of >14 days. Twelve (25.5%) patients had thrombosis of the inferior vena cava and the iliofemoral segments. During the index procedure, unobstructed flow was reestablished in 47 of 53 (88.6%) limbs in 41 of 47 (87.2%) patients (primary endpoint) with no MAEs through 30 days. Overall, unobstructed flow was restored in 50 of 53 (94.3%) limbs and in 44 of 47 (93.6%) patients.
Conclusions: Successful single-session treatment of patients with acute iliocaval and iliofemoral DVT is feasible with a high rate of efficacy and a low rate of adverse events. Such patients may be treated on an outpatient basis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jvir.2021.10.011 | DOI Listing |
Am Surg
May 2025
Division of Vascular and Endovascular Surgery, Department of Surgery, Irvine School of Medicine, University of California, Orange, CA, USA.
Percutaneous thrombectomy of the inferior vena cava (IVC) and complex iliocaval lesions may cause thromboembolism. The Inari Protrieve sheath is a device with a 33.5 mm funnel at the tip that can serve as embolic protection during thrombectomy procedures to mitigate the risk of pulmonary embolisms (PEs).
View Article and Find Full Text PDFPurposeTo evaluate longer term outcomes of the Zilver Vena Venous Stent in patients undergoing venous stenting.Materials and MethodsPatients with iliofemoral obstructive venous disease and treated with venous stents were retrospectively enrolled in a physician-led real-world data collection effort. Results were analyzed by etiologies: post-thrombotic syndrome (PTS), non-thrombotic iliac vein lesion (NIVL), and iliocaval acute deep vein thrombosis (aDVT).
View Article and Find Full Text PDFJ Vasc Interv Radiol
March 2025
Department of Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands.
Purpose: To identify the risk of deep femoral vein (DFV) and/or femoral vein (FV) inflow disease on venous stent patency loss in postthrombotic syndrome (PTS).
Materials And Methods: This single-center retrospective study included limbs with iliofemoral and iliocaval stents for PTS. Single-vessel and double-vessel inflow disease were defined on the basis of imaging of possible postthrombotic changes in the DFV/FV.
Cardiovasc Intervent Radiol
December 2024
Department of Interventional Radiology, Galway University Hospital, Galway, Ireland.
Introduction: Deep venous stent placement has developed into a primary treatment modality for venous obstruction in recent decades. Reported rates of complications are low in the literature and are based mainly on case reports and single-centre cohorts. Interventionalists performing these procedures must be aware of the occurrence of complications associated with stent placement to counsel patients adequately and promote avoidance through optimal procedural approach.
View Article and Find Full Text PDFCurr Oncol
July 2024
Department of Radiology, Vancouver General Hospital, Vancouver, BC V5Z 1M9, Canada.
Inferior vena cava (IVC) compression secondary to mass effect is accompanied by edema, ascites, back and abdominal pain, and central nervous system symptoms. Most IVC syndrome cases described in the literature focus on the focal treatment of IVC lesions, and reports of complete iliocaval reconstructions secondary to malignant IVC syndrome in the palliative context are limited. In this case report, we describe the clinical presentation, technical approach, and symptomatic outcomes of a patient with extensive malignant compression and invasion of the iliofemoral venous system.
View Article and Find Full Text PDF